(Q33534372)

27 July 2017

1 reference

title

Endothelin antagonists (English)

1 reference

27 July 2017

A Benigni

1

0 references

Giuseppe Remuzzi

object named as

G Remuzzi

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

353

1 reference

27 July 2017

issue

9147

1 reference

27 July 2017

page(s)

133-138

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Endothelins in the control of cardiovascular and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Venous smooth muscle contains vasoconstrictor ETB-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Hemodynamic effects of a selective endothelin--a receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Hypertension associated with endothelin-secreting malignant hemangioendothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Increased plasma endothelin level in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Plasma endothelin in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Increased plasma concentrations of endothelin in congestive heart failure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Endothelin in human congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Biological role for the endothelin-A receptor in aortic cross-clamping

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

BQ-123, a specific endothelin (ETA) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Bosentan, an orally active endothelin antagonist: effect on the renal response to contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Effect of a specific endothelin A receptor antagonist on murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Contribution of endogenous generation of endothelin-1 to basal vascular tone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ET A Receptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Bosentan in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

The renoprotective potential of endothelin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

A role for endothelin in the maintenance of post-ischaemic renal failure in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909423-9

7 January 2021

10.1016/S0140-6736(98)09423-9

Identifiers

DOI

1 reference

27 July 2017

1 reference